subject area of

• A blueprint for HIV vaccine discovery  Academic Article
• A diffuse infiltrative CD8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection: a host immune response associated with HLA-DR5  Academic Article
• A double-mimetic peptide efficiently neutralizes HIV-1 by bridging the CD4- and coreceptor-binding sites of gp120  Academic Article
• A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control  Academic Article
• A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A  Academic Article
• A method for identification of hiv gp140 binding memory b cells in human blood  Academic Article
• A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene  Academic Article
• A next-generation cleaved, soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, expresses multiple epitopes for broadly neutralizing but not non-neutralizing antibodies  Academic Article
• A nonself sugar mimic of the hiv glycan shield shows enhanced antigenicity  Academic Article
• A polymorphism in the leptin gene promoter is associated with anemia in patients with HIV disease  Academic Article
• A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples  Academic Article
• A tyrosine-rich region in the N terminus of CCR5 is important for human immunodeficiency virus type 1 entry and mediates an association between gp120 and CCR5  Academic Article
• A tyrosine-sulfated peptide derived from the heavy-chain CDR3 region of an HIV-1-neutralizing antibody binds gp120 and inhibits HIV-1 infection  Academic Article
• A vaccine for hiv type 1: The antibody perspective  Academic Article
• A validated assay by liquid chromatography-tandem mass spectrometry for the simultaneous quantification of elvitegravir and rilpivirine in HIV positive patients  Academic Article
• A whole-genome association study of major determinants for host control of HIV-1  Academic Article
• ADME pathway approach for pharmacogenetic studies of anti-HIV therapy  Academic Article
• Absence of specific mucosal antibody responses in hiv-exposed uninfected sex workers from the gambia  Academic Article
• Activated platelet-T-cell conjugates in peripheral blood of patients with HIV infection: coupling coagulation/inflammation and T cells  Academic Article
• Advances in targeting nucleocapsid-nucleic acid interactions in HIV-1 therapy  Academic Article
• Adverse events to antiretrovirals in the Swiss HIV Cohort Study: Effect on mortality and treatment modification  Academic Article
• An HIV-encoded antisense long noncoding RNA epigenetically regulates viral transcription  Academic Article
• An analog of the natural steroidal alkaloid cortistatin A potently suppresses Tat-dependent HIV transcription  Academic Article
• An aptamer that neutralizes r5 strains of hiv-1 binds to core residues of gp120 in the ccr5 binding site  Academic Article
• Analysis of HIV-1 expression level and sense of transcription by high-throughput sequencing of the infected cell  Academic Article
• Analysis of neutralization specificities in polyclonal sera derived from human immunodeficiency virus type 1-infected individuals  Academic Article
• Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo  Academic Article
• Another HIV vaccine failure: where to next?  Academic Article
• Anti-HIV-1 gene expressing lentiviral vectors as an adjunctive therapy for HIV-1 infection  Academic Article
• Antibodies that cross-neutralize the tier-2 pseudoviruses are produced in antiretroviral-naive HIV-1-infected children from northern India  Academic Article
• Antibody conjugation approach enhances breadth and potency of neutralization of anti-HIV-1 antibodies and CD4-IgG  Academic Article
• Antibody neutralization-resistant primary isolates of human immunodeficiency virus type 1  Academic Article
• Antibody protects macaques against vaginal challenge with a pathogenic r5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro  Academic Article
• Antibody recognition of a carbohydrate epitope: a template for HIV vaccine design  Academic Article
• Antibody responses to envelope glycoproteins in HIV-1 infection  Academic Article
• Antiretroviral drug resistance mutations in the reverse transcriptase gene of HIV-1 isolates from Northern Indian patients: a follow-up study  Academic Article
• Antiretroviral drug toxicity in relation to pharmacokinetics, metabolic profile and pharmacogenetics  Academic Article
• Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel  Academic Article
• Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel  Academic Article
• Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel  Academic Article
• Apoptosis induced by HIV infection in H9 T cells is blocked by ICE-family protease inhibition but not by a Fas(CD95) antagonist  Academic Article
• Are viral-encoded microRNAs mediating latent HIV-1 infection?  Academic Article
• Are viral-encoded microRNAs mediating latent HIV-1 infection?  Academic Article
• Association of pharmacogenetic markers with premature discontinuation of first-line anti-HIV therapy: an observational cohort study  Academic Article
• Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls  Academic Article
• Associations between phylogenetic clustering and HLA profile among HIV-infected individuals in San Diego, California  Academic Article
• B cell recognition of the conserved hiv-1 co-receptor binding site is altered by endogenous primate cd4  Academic Article
• Binding antibody responses to the immunogenic regions of viral envelope in HIV-1-infected Indian children  Academic Article
• Biochemical and immunogenic characterization of soluble human immunodeficiency virus type 1 envelope glycoprotein trimers expressed by semliki forest virus  Academic Article
• Bioengineering and semisynthesis of an optimized cyclophilin inhibitor for treatment of chronic viral infection  Academic Article
• Biology of CCR5 and its role in HIV infection and treatment  Academic Article
• Blind prediction of HIV integrase binding from the SAMPL4 challenge  Academic Article
• Bone marrow plasma cells are a primary source of serum HIV-1-specific antibodies in chronically infected individuals  Academic Article
• Breadth of human immunodeficiency virus-specific neutralizing activity in sera: Clustering analysis and association with clinical variables  Academic Article
• Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target  Academic Article
• Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals  Academic Article
• Broad neutralization coverage of HIV by multiple highly potent antibodies  Academic Article
• Broadly neutralizing HIV antibodies define a glycan-dependent epitope on the prefusion conformation of gp41 on cleaved envelope trimers  Academic Article
• Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses  Academic Article
• Broadly neutralizing antibody responses in a large longitudinal Sub-Saharan HIV primary infection cohort  Academic Article
• Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers  Academic Article
• CCL3L1 and HIV/AIDS susceptibility  Academic Article
• CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro  Academic Article
• CCR5 promoter polymorphism determines macrophage CCR5 density and magnitude of HIV-1 propagation in vitro  Academic Article
• CD4+ cell turnover  Academic Article
• CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies  Academic Article
• CRISPR-mediated activation of latent HIV-1 expression  Academic Article
• CXCL13 is a plasma biomarker of germinal center activity  Academic Article
• Can gene delivery close the door to HIV-1 entry after escape?  Academic Article
• Cat retroviruses and human retroviruses: elements of comparison  Academic Article
• Cell disposition of raltegravir and newer antiretrovirals in HIV-infected patients: high inter-individual variability in raltegravir cellular penetration  Academic Article
• Cell-specific RNA aptamer against human CCR5 specifically targets HIV-1 susceptible cells and inhibits HIV-1 infectivity  Academic Article
• Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy  Academic Article
• Challenges for structure-based HIV vaccine design  Academic Article
• Changes in HIV-1 tropism: clinical and prognostic consequences  Academic Article
• Changes in the V3 region of gp 120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta 32 heterozygote  Academic Article
• Characteristics of memory B cells elicited by a highly efficacious HPV vaccine in subjects with no pre-existing immunity  Academic Article
• Characterization of human immunodeficiency virus (HIV)-2 vector mobilization by HIV-1  Academic Article
• Characterization of plasmablasts in the blood of HIV-infected viremic individuals: Evidence for nonspecific immune activation  Academic Article
• Characterization of primary isolate-like variants of simian-human immunodeficiency virus  Academic Article
• Chemokine receptors in HIV-1 and SIV infection  Academic Article
• Clinical applications of genome editing to HIV cure  Academic Article
• Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism  Academic Article
• Cloning and characterization of functional subtype A HIV-1 envelope variants transmitted through breastfeeding  Academic Article
• CoVaMa: Co-Variation Mapper for disequilibrium analysis of mutant loci in viral populations using next-generation sequence data  Academic Article
• Cohort profile: the Swiss HIV Cohort study  Academic Article
• Combination of methamphetamine and HIV-1 gp120 causes distinct long-term alterations of behavior, gene expression, and injury in the central nervous system  Academic Article
• Common genetic variation and the control of HIV-1 in humans  Academic Article
• Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque  Academic Article
• Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer  Academic Article
• Consequences of secondary or coinfections for immunity  Academic Article
• Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy  Academic Article
• Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons  Academic Article
• Contribution of genome-wide significant single-nucleotide polymorphisms and antiretroviral therapy to dyslipidemia in HIV-infected individuals: a longitudinal study  Academic Article
• Correlation of naturally occurring HIV-1 resistance to DEB025 with capsid amino acid polymorphisms  Academic Article
• Cortical neuronal cytoskeletal changes associated with fiv infection  Academic Article
• Cross-neutralizing activity of human anti-V3 monoclonal antibodies derived from non-B clade HIV-1 infected individuals  Academic Article
• Cryopreservation of human mucosal tissues  Academic Article
• Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine design  Academic Article
• Crystallization and preliminary structure determination of an intact human immunoglobulin, b12: An antibody that broadly neutralizes primary isolates of HIV-1  Academic Article
• Cta1-dd adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization  Academic Article
• Current V3 genotyping algorithms are inadequate for predicting X4 co-receptor usage in clinical isolates  Academic Article
• DDX1 is an RNA-dependent ATPase involved in HIV-1 Rev function and virus replication  Academic Article
• Deep sequencing of protease inhibitor resistant HIV patient isolates reveals patterns of correlated mutations in Gag and protease  Academic Article
• Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds  Academic Article
• Design, synthesis, and biological evaluation of a biyouyanagin compound library  Academic Article
• Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants  Academic Article
• Determinants of polyreactivity in a large panel of recombinant human antibodies from hiv-1 infection  Academic Article
• Determinants of sustained viral suppression in HIV-infected patients with self-reported poor adherence to antiretroviral therapy  Academic Article
• Determination of unbound antiretroviral drug concentrations by a modified ultrafiltration method reveals high variability in the free fraction  Academic Article
• Development and validation of decision rules to guide frequency of monitoring CD4 cell count in HIV-1 infection before starting antiretroviral therap  Academic Article
• Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies  Academic Article
• Didehydro-Cortistatin A: a new player in HIV-therapy?  Academic Article
• Didehydro-cortistatin A inhibits HIV-1 Tat mediated neuroinflammation and prevents potentiation of cocaine reward in Tat transgenic mice  Academic Article
• Differential expression profiles of apoptosis-affecting genes in hiv-infected cell lines and patient t cells  Academic Article
• Differential microRNA regulation of HLA-C expression and its association with HIV control  Academic Article
• Differential tropism and replication kinetics of human immunodeficiency virus type 1 isolates in thymocytes: coreceptor expression allows viral entry, but productive infection of distinct subsets is determined at the postentry level  Academic Article
• Discordant impact of HLA on viral replicative capacity and disease progression in pediatric and adult HIV infection  Academic Article
• Discovery of a distinct chemical and mechanistic class of allosteric HIV-1 integrase inhibitors with antiretroviral activity  Academic Article
• Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3  Academic Article
• Disentangling human tolerance and resistance against HIV  Academic Article
• Dissecting the neutralizing antibody-specificities of broadly neutralizing sera from human immunodeficiency virus type 1-infected donors  Academic Article
• Does tenofovir influence efavirenz pharmacokinetics?  Academic Article
• Dopamine increases CD14(+)CD16(+) monocyte transmigration across the blood brain barrier: implications for substance abuse and HIV neuropathogenesis  Academic Article
• Dopamine increases CD14+CD16+ monocyte migration and adhesion in the context of substance abuse and HIV neuropathogenesis  Academic Article
• Dosage optimization of treatments using population pharmacokinetic modeling and simulation  Academic Article
• Drift of the HIV-1 envelope glycoprotein gp120 toward increased neutralization resistance over the course of the epidemic: a comprehensive study using the most potent and broadly neutralizing monoclonal antibodies  Academic Article
• Drug induced increases in CNS dopamine alter monocyte, macrophage and T cell functions: implications for HAND  Academic Article
• Dual-color HIV reporters trace a population of latently infected cells and enable their purification  Academic Article
• Dynamic models of viral replication and latency  Academic Article
• Dynamics of HIV latency and reactivation in a primary CD4+ T cell model.  Academic Article
• Dyslipidemia in HIV-infected individuals: from pharmacogenetics to pharmacogenomics  Academic Article
• Efavirenz intoxication due to a new CYP2B6 constellation  Academic Article
• Effect of polyanion-resistance on HIV-1 infection  Academic Article
• Elicitation of simian immunodeficiency virus-specific cytotoxic t lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination  Academic Article
• Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types  Academic Article
• Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy  Academic Article
• Enhanced recognition and neutralization of HIV-1 by antibody-derived CCR5-mimetic peptide variants  Academic Article
• Envelope diversity, characteristics of V3 region and predicted co-receptor usage of human immunodeficiency viruses infecting north Indians  Academic Article
• Erythropoietin plus insulin-like growth factor-I protects against neuronal damage in a murine model of human immunodeficiency virus-associated neurocognitive disorders  Academic Article
• Escalating morphine exposures followed by withdrawal in feline immunodeficiency virus-infected cats: a model for HIV infection in chronic opiate abusers  Academic Article
• Establishment of HIV-1 resistance in CD4(+) T cells by genome editing using zinc-finger nucleases  Academic Article
• Estimating the respective contributions of human and viral genetic variation to HIV control  Academic Article
• Evaluation of gp160 vaccinees in the hu-PBL-SCID mouse model  Academic Article
• Evaluation of protective immunity to HIV-1 in human PBL-SCID mice  Academic Article
• Evolution of a TRIM5-CypA splice isoform in old world monkeys  Academic Article
• Evolutionary genomics and HIV restriction factors  Academic Article
• Evolutionary trajectories of primate genes involved in HIV pathogenesis  Academic Article
• Ex vivo cytosolic delivery of functional macromolecules to immune cells  Academic Article
• Expanded breadth of virus neutralization after immunization with a multiclade envelope hiv vaccine candidate  Academic Article
• Extreme genetic divergence is required for coreceptor switching in HIV-1 subtype C  Academic Article
• Fc receptor but not complement binding is important in antibody protection against HIV  Academic Article
• Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV  Academic Article
• Focused dampening of antibody response to the immunodominant variable loops by engineered soluble gp140  Academic Article
• Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing  Academic Article
• Folding and function in α/β-peptides: targets and therapeutic applications  Academic Article
• Free and total plasma levels of lopinavir during pregnancy, at delivery and postpartum: implications for dosage adjustments in pregnant women  Academic Article
• Frequency and phenotype of human immunodeficiency virus envelope-specific b cells from patients with broadly cross-neutralizing antibodies  Academic Article
• Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion  Academic Article
• Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody  Academic Article
• Functional optimization of broadly neutralizing HIV-1 antibody 10E8 by promotion of membrane interactions  Academic Article
• GB virus C and mortality from HIV infection  Academic Article
• Gene expression changes consistent with neuroAIDS and impaired working memory in HIV-1 transgenic rats  Academic Article
• Generalized immunosuppression: How viruses undermine the immune response  Academic Article
• Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule ccr5 inhibitor  Academic Article
• Genetic attributes of cerebrospinal fluid-derived HIV-1 env  Academic Article
• Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection  Academic Article
• Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy  Academic Article
• Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation  Academic Article
• Genetic studies in systemic autoimmunity and aging  Academic Article
• Genome-wide mRNA expression correlates of viral control in CD4+ T-cells from HIV-1-infected individuals  Academic Article
• Genomic approaches to the study of HIV‐1 acquisition  Academic Article
• Genomics meets HIV-1  Academic Article
• Genomics of HIV infection  Academic Article
• Global landscape of HIV-human protein complexes  Academic Article
• Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation  Academic Article
• Guanylate binding protein (GBP) 5 is an interferon-inducible inhibitor of HIV-1 infectivity  Academic Article
• GuavaH: a compendium of host genomic data in HIV biology and disease  Academic Article
• Gut Lactobacillales are associated with higher CD4 and less microbial translocation during HIV infection  Academic Article
• HIV entry inhibitors  Academic Article
• HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells  Academic Article
• HIV latency and the noncoding RNA therapeutic landscape  Academic Article
• HIV, Tat and dopamine transmission  Academic Article
• HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1  Academic Article
• HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection  Academic Article
• HIV-1 elite controllers: Beware of super-infections  Academic Article
• HIV-1 infection impairs regulatory T-cell suppressive capacity on a per-cell basis  Academic Article
• HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway  Academic Article
• HIV-1 neutralizing antibodies induced by native-like envelope trimers  Academic Article
• HIV-1 neutralizing antibodies induced by native-like envelope trimers  Academic Article
• HIV-1 subtype A envelope variants from early in infection have variable sensitivity to neutralization and to inhibitors of viral entry  Academic Article
• HIV-related neurotoxicity  Academic Article
• HIV/gp120 decreases adult neural progenitor cell proliferation via checkpoint kinase-mediated cell-cycle withdrawal and G1 arrest  Academic Article
• HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy  Academic Article
• HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C  Academic Article
• Helicobacter pylori VacA toxin inhibits human immunodeficiency virus infection of primary human T cells  Academic Article
• Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection  Academic Article
• Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus  Academic Article
• Herpesviruses and HIV-1 drug resistance mutations influence the virologic and immunologic milieu of the male genital tract  Academic Article
• Heterologous envelope immunogens contribute to aids vaccine protection in rhesus monkeys  Academic Article
• High-resolution definition of vaccine-elicited b cell responses against the hiv primary receptor binding site  Academic Article
• Highly efficient neutralization by plasma antibodies from human immunodeficiency virus type-1 infected individuals on antiretroviral drug therapy  Academic Article
• Highly pathogenic adapted HIV-1 strains limit host immunity and dictate rapid disease progression  Academic Article
• Highly potent RANTES analogues either prevent CCR5-using human immunodeficiency virus type 1 infection in vivo or rapidly select for CXCR4-using variants  Academic Article
• Highly potent hiv-specific antibody neutralization in vitro translates into effective protection against mucosal shiv challenge in vivo  Academic Article
• Hijacking and exploitation of il-10 by intracellular pathogens  Academic Article
• Hiv type 1 env precursor cleavage state affects recognition by both neutralizing and nonneutralizing gp41 antibodies  Academic Article
• Hiv-1 env(gp140) trimers elicit neutralizing antibodies without efficient induction of conformational antibodies  Academic Article
• Hiv-1 neutralization: Mechanisms and relevance to vaccine design  Academic Article
• Host and viral genetic correlates of clinical definitions of HIV-1 disease progression  Academic Article
• Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production  Academic Article
• Host genes important to HIV replication and evolution  Academic Article
• Host genetics and HIV-1: the final phase?  Academic Article
• How HIV changes its tropism: evolution and adaptation?  Academic Article
• Human circulating PD-(+)1CXCR3(-)CXCR5(+) memory Tfh cells are highly functional and correlate with broadly neutralizing HIV antibody responses  Academic Article
• Human immunodeficiency virus (HIV) infection of human macrophages is increased by dopamine: a bridge between HIV-associated neurologic disorders and drug abuse  Academic Article
• Human immunodeficiency virus infection of human cells transplanted to severe combined immunodeficient mice  Academic Article
• Human immunodeficiency virus infection of human-PBL-SCID mice  Academic Article
• Human immunodeficiency virus type 1 elite neutralizers: Individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm  Academic Article
• Human immunodeficiency virus type 1 infection of neonatal severe combined immunodeficient mice xenografted with human cord blood cells  Academic Article
• Human xenograft models for virus infection  Academic Article
• Human-immunodeficiency-virus infection of human brain capillary endothelial-cells occurs via a cd4 galactosylceramide-independent mechanism  Academic Article
• IDEPI: rapid prediction of HIV-1 antibody epitopes and other phenotypic features from sequence data using a flexible machine learning platform  Academic Article
• IL-10: achieving balance during persistent viral infection  Academic Article
• Identification and characterization of a peptide that specifically binds the human, broadly neutralizing anti-human immunodeficiency virus type 1 antibody b12  Academic Article
• Identification of CD4-binding site dependent plasma neutralizing antibodies in an HIV-1 Infected Indian individual  Academic Article
• Identification of an HIV-1 clade A envelope that exhibits broad antigenicity and neutralization sensitivity and elicits antibodies targeting three distinct epitopes  Academic Article
• Identification of common features in prototype broadly neutralizing antibodies to HIV envelope V2 apex to facilitate vaccine design  Academic Article
• Identifying safety concerns from genetic data: lessons from the development of CCR5 inhibitors  Academic Article
• Il-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of hiv infection  Academic Article
• Immunization for HIV-1 broadly neutralizing antibodies in human Ig knockin mice  Academic Article
• Immunization with recombinant hla classes i and ii, hiv-1 gp140, and siv p27 elicits protection against heterologous shiv infection in rhesus macaques  Academic Article
• Immunochemistry of the dominating antigenic region ala582 to cys604 in the transmembranous protein of simian and human immunodeficiency virus  Academic Article
• Immunodeficient mice xenografted with human lymphoid cells: new models for in vivo studies of human immunobiology and infectious diseases  Academic Article
• Impact of phenotype definition on genome-wide association signals: empirical evaluation in human immunodeficiency virus type 1 infection  Academic Article
• Impact of seminal cytomegalovirus replication on HIV-1 dynamics between blood and semen  Academic Article
• Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals  Academic Article
• In vitro whole-genome analysis identifies a susceptibility locus for HIV-1  Academic Article
• In vivo profiling and distribution of known and novel phase I and phase II metabolites of efavirenz in plasma, urine, and cerebrospinal fluid  Academic Article
• Increased hiv-1 vaccine efficacy against viruses with genetic signatures in env v2  Academic Article
• Inflammatory cytokines: Putative regulators of neuronal and neuro-endocrine function  Academic Article
• Inhibition of hiv-1 entry by antibodies: Potential viral and cellular targets  Academic Article
• Inhibition of virus attachment to cd4(+) target cells is a major mechanism of t cell line-adapted hiv-1 neutralization  Academic Article
• Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1  Academic Article
• Insights into the trimeric HIV-1 envelope glycoprotein structure  Academic Article
• Is resistance futile?  Academic Article
• Isobaric tagging-based quantification by mass spectrometry of differentially regulated proteins in synaptosomes of HIV/gp120 transgenic mice: implications for HIV-associated neurodegeneration  Academic Article
• Key gp120 glycans pose roadblocks to the rapid development of VRC01-class antibodies in an HIV-1-infected Chinese donor  Academic Article
• Knowledge is Power! Increased Provider Knowledge Scores Regarding Pre-exposure Prophylaxis (PrEP) are Associated with Higher Rates of PrEP Prescription and Future Intent to Prescribe PrEP  Academic Article
• LILRB2 interaction with HLA class I correlates with control of HIV-1 infection  Academic Article
• Lentiviral-mediated delivery of siRNAs for antiviral therapy  Academic Article
• Lentivirus-mediated RNA interference therapy for human immunodeficiency virus type 1 infection  Academic Article
• Lessons from the cat: Feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1  Academic Article
• Limited or no protection by weakly or nonneutralizing antibodies against vaginal shiv challenge of macaques compared with a strongly neutralizing antibody  Academic Article
• Live simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry  Academic Article
• Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells  Academic Article
• Long-term effect of depot medroxyprogesterone acetate on vaginal microbiota, epithelial thickness and HIV target cells  Academic Article
• Long-term nonprogressive human immunodeficiency virus-1 infection in a kidney allograft recipient  Academic Article
• Longitudinal analysis of behavioral, neurophysiological, viral and immunological effects of SIV infection in rhesus monkeys  Academic Article
• Lysis of human immunodeficiency virus type 1 by a specific secreted human phospholipase a(2)  Academic Article
• Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints  Academic Article
• Maturation pathway from germline to broad HIV-1 neutralizer of a CD4-mimic antibody  Academic Article
• Mechanisms of HIV entry into the CNS: increased sensitivity of HIV infected CD14+CD16+ monocytes to CCL2 and key roles of CCR2, JAM-A, and ALCAM in diapedesis  Academic Article
• Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors  Academic Article
• Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study  Academic Article
• Methamphetamine increases brain viral load and activates natural killer cells in simian immunodeficiency virus-infected monkeys  Academic Article
• Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders  Academic Article
• Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies  Academic Article
• Murine antibody responses to cleaved soluble HIV-1 envelope trimers are highly restricted in specificity  Academic Article
• N-butyldeoxynojirimycin is a broadly effective anti-hiv therapy significantly enhanced by targeted liposome delivery  Academic Article
• Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy  Academic Article
• Neuroelectric assessment of hiv: Eeg, erp, and viral load  Academic Article
• Neuronal injury associated with HIV-1 and potential treatment with calcium-channel and NMDA antagonists  Academic Article
• Neuronal injury associated with HIV-1: Approaches to treatment  Academic Article
• Neutralization of tier-2 viruses and epitope profiling of plasma antibodies from human immunodeficiency virus type 1 infected donors from India  Academic Article
• Neutralization potential of the plasma of HIV-1 infected Indian patients in the context of Anti-V3 antibody content and antiretroviral theraphy  Academic Article
• Neutralization takes precedence over IgG or IgA isotype-related functions in mucosal HIV-1 antibody-mediated protection  Academic Article
• Neutralizing antibodies generated during natural hiv-1 infection: Good news for an hiv-1 vaccine?  Academic Article
• Neutralizing antibodies have limited effects on the control of established HIV-1 infection in vivo  Academic Article
• Neutralizing epitopes in the membrane-proximal external region of hiv-1 gp41 are influenced by the transmembrane domain and the plasma membrane  Academic Article
• Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to t cells  Academic Article
• New class of HIV-1 integrase (IN) inhibitors with a dual mode of action  Academic Article
• No longitudinal mitochondrial DNA sequence changes in HIV-infected individuals with and without lipoatrophy  Academic Article
• Nonhuman primate models and the failure of the merck hiv-1 vaccine in humans  Academic Article
• One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the blt model for evaluation of new microbicide candidates  Academic Article
• Optimal combinations of broadly neutralizing antibodies for prevention and treatment of HIV-1 clade C  Academic Article
• Orosomucoid (α1-acid glycoprotein) plasma concentration and genetic variants: Effects on human immunodeficiency virus protease inhibitor clearance and cellular accumulation  Academic Article
• P3a and p3b auditory erps in hiv patients receiving anti-viral medication  Academic Article
• Passive immunization with a human monoclonal antibody protects hu-pbl-scid mice against challenge by primary isolates of hiv-1  Academic Article
• Pathogenesis of HIV-1 infection within bone marrow cells  Academic Article
• Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals  Academic Article
• Pharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases  Academic Article
• Phase 1 safety and immunogenicity evaluation of a multiclade hiv-1 DNA candidate vaccine  Academic Article
• Phase 1 safety and immunogenicity evaluation of a multiclade hiv-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vector  Academic Article
• Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load  Academic Article
• Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection  Academic Article
• Population pharmacokinetic analysis and pharmacogenetics of raltegravir in HIV-positive and healthy individuals  Academic Article
• Population pharmacokinetics of atazanavir in patients with human immunodeficiency virus infection  Academic Article
• Potent neutralization of primary human immunodeficiency virus clade c isolates with a synergistic combination of human monoclonal antibodies raised against clade b  Academic Article
• Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study)  Academic Article
• Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5  Academic Article
• Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to hiv-1 gp120  Academic Article
• Primary isolates of human-immunodeficiency-virus type-1 are relatively resistant to neutralization by monoclonal-antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120  Academic Article
• Primate immune responses to HIV-1 Env formulated in the saponin-based adjuvant AbISCO-100 in the presence or absence of TLR9 co-stimulation  Academic Article
• Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen  Academic Article
• Privacy-preserving genomic testing in the clinic: a model using HIV treatment  Academic Article
• Production and characterization of human anti-V3 monoclonal antibodies from the cells of HIV-1 infected Indian donors  Academic Article
• Profiling human antibody responses by integrated single-cell analysis  Academic Article
• Programed death-1/programed death-ligand 1 expression in lymph nodes of HIV infected patients: results of a pilot safety study in rhesus macaques using anti-programed death-ligand 1 (Avelumab)  Academic Article
• Progress and prospects: RNA-based therapies for treatment of HIV infection  Academic Article
• Promiscuous glycan site recognition by antibodies to the high-mannose patch of gp120 broadens neutralization of HIV  Academic Article
• Protective efficacy of broadly neutralizing antibodies with incomplete neutralization activity against simian-human immunodeficiency virus in rhesus monkeys  Academic Article
• Randomized controlled trial of daily text messages to support adherence to preexposure prophylaxis in individuals at risk for human immunodeficiency virus: the TAPIR study  Academic Article
• Rapid deep sequencing of patient-derived HIV with ion semiconductor technology  Academic Article
• Rapid development of glycan-specific, broad, and potent anti-HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque  Academic Article
• Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization  Academic Article
• Rapid loss of CD4+ T cells in human-PBL-SCID mice by noncytopathic HIV isolates  Academic Article
• Rational HIV immunogen design to target specific germline B cell receptors  Academic Article
• Rational antibody-based HIV-1 vaccine design: current approaches and future directions  Academic Article
• Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to hiv-1  Academic Article
• Reactivation of latent HIV-1 expression by engineered TALE transcription factors  Academic Article
• Recognition properties of a panel of human recombinant fab fragments to the cd4 binding-site of gp120 that show differing abilities to neutralize human-immunodeficiency-virus type-1  Academic Article
• Recombinant HIV envelope proteins fail to engage germline versions of anti-CD4bs bNAbs.  Academic Article
• Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex  Academic Article
• Recombinant human monoclonal antibody igg1b12 neutralizes diverse human immunodeficiency virus type 1 primary isolates  Academic Article
• Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections  Academic Article
• Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions  Academic Article
• Regulatory T cells expanded from HIV-1-infected individuals maintain phenotype, TCR repertoire and suppressive capacity  Academic Article
• Relation of stressors and depressive symptoms to clinical progression of viral illness  Academic Article
• Relative reactivity of HIV-1 polyclonal plasma antibodies directed to V3 and MPER regions suggests immunodominance of V3 over MPER and dependence of high anti-V3 antibody titers on virus persistence  Academic Article
• Release of hydrogen-peroxide from human t-cell lines and normal lymphocytes co-infected with hiv-1 and mycoplasma  Academic Article
• Relevance of the antibody response against human immunodeficiency virus type 1 envelope to vaccine design  Academic Article
• Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates  Academic Article
• Reversible reprogramming of circulating memory T follicular helper cell function during chronic HIV infection  Academic Article
• Review of the twelfth west coast retrovirus meeting  Academic Article
• Rhesus macaque B-cell responses to an HIV-1 trimer vaccine revealed by unbiased longitudinal repertoire analysis  Academic Article
• Robust neutralizing antibodies elicited by HIV-1 JRFL envelope glycoprotein trimers in nonhuman primates  Academic Article
• Role of common human TRIM5α variants in HIV-1 disease progression  Academic Article
• Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization  Academic Article
• Role of seminal shedding of herpesviruses in HIV Type 1 transmission  Academic Article
• Role of viral strains and host genes in determining levels of immune-complexes in a model system - implications for hiv-infection  Academic Article
• Safety and efficacy of a tCD25 preselective combination anti-HIV lentiviral vector in human hematopoietic stem and progenitor cells  Academic Article
• Safety concerns about CCR5 as an antiviral target  Academic Article
• Selection of unadapted, pathogenic SHIVs encoding newly transmitted HIV-1 envelope proteins  Academic Article
• Selection pressure on hiv-1 envelope by broadly neutralizing antibodies to the conserved cd4-binding site  Academic Article
• Semen-derived amyloid fibrils drastically enhance HIV infection  Academic Article
• Sequence and structural convergence of broad and potent hiv antibodies that mimic cd4 binding  Academic Article
• Sex differences in antiretroviral therapy initiation in pediatric HIV infection  Academic Article
• Sexual transmission of predicted CXCR4-tropic HIV-1 likely originating from the source partner's seminal cells  Academic Article
• Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides  Academic Article
• Simian immunodeficiency virus engrafted with human immunodeficiency virus type 1 (hiv-1)-specific ipitopes: Replication, neutralization, and survey of hiv-1-positive plasma  Academic Article
• Single-cell analysis identifies cellular markers of the HIV permissive cell  Academic Article
• Small animal models for acquired immune deficiency syndrome (AIDS) research  Academic Article
• Small molecule regulation of protein conformation by binding in the flap of HIV protease  Academic Article
• Specific killing of hiv-infected lymphocytes by a recombinant immunotoxin directed against the hiv-1 envelope glycoprotein  Academic Article
• Stapled HIV-1 peptides recapitulate antigenic structures and engage broadly neutralizing antibodies  Academic Article
• State of genomics and epigenomics research in the perspective of HIV cure  Academic Article
• Stimulation of the primary anti-hiv antibody response by ifn-alpha in patients with acute hiv-1 infection  Academic Article
• Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120  Academic Article
• Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers  Academic Article
• Structural interactions between chemokine receptors, gp120 Env and CD4  Academic Article
• Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formation  Academic Article
• Structure-based vaccine design in hiv: Blind men and the elephant?  Academic Article
• Studies of HIV infection and the development of Epstein-Barr virus-related B cell lymphomas following transfer of human lymphocytes to mice with severe combined immunodeficiency  Academic Article
• Successful efavirenz dose reduction guided by therapeutic drug monitoring  Academic Article
• Sustained local delivery of structurally diverse HIV-1 microbicides released from sublimation enthalpy controlled matrices  Academic Article
• Syndecan-fc hybrid molecule as a potent in vitro microbicidal anti-hiv-1 agent  Academic Article
• Syndecans and HIV-1 pathogenesis  Academic Article
• Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages  Academic Article
• T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery  Academic Article
• TGF beta and HIV infection  Academic Article
• TNF-alpha and TLR agonists increase susceptibility to HIV-1 transmission by human langerhans cells ex vivo  Academic Article
• Targeting the HIV-1 spike and coreceptor with bi- and trispecific antibodies for single-component broad inhibition of entry  Academic Article
• Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity  Academic Article
• The antibody response in HIV-1 infection  Academic Article
• The antiviral activity of HIV-specific CD8+ CTL clones is limited by elimination due to encounter with HIV-infected targets  Academic Article
• The bis-azo compound FP-21399 inhibits HIV-1 replication by preventing viral entry  Academic Article
• The ccr5 receptor acts as an alloantigen in ccr5 delta 32 homozygous individuals: Identification of chemokine- and hiv-1-blocking human antibodies  Academic Article
• The cell tropism of human immunodeficiency virus type 1 determines the kinetics of plasma viremia in SCID mice reconstituted with human peripheral blood leukocytes  Academic Article
• The challenges of eliciting neutralizing antibodies to hiv-1 and to influenza virus  Academic Article
• The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus  Academic Article
• The emerging role of long non-coding RNAs in HIV infection  Academic Article
• The genomic signature of population reconnection following Isolation: from theory to HIV  Academic Article
• The hiv-1 envelope glycoproteins: Fusogens, antigens, and immunogens  Academic Article
• The impact of vaccination on the breadth and magnitude of the antibody response to influenza A viruses in HIV-infected individuals  Academic Article
• The inhibitor of apoptosis proteins antagonist Debio 1143 promotes the PD-1 blockade-mediated HIV load reduction in blood and tissues of humanized mice 
• The interplay between host genetic variation, viral replication, and microbial translocation in untreated HIV-infected individuals  Academic Article
• The membrane-proximal external region of hiv-1 gp41: A vaccine target worth exploring  Academic Article
• The nature of the autoimmune antibody repertoire in human-immunodeficiency-virus type-1 infection  Academic Article
• The novel cyclophilin inhibitor CPI-431-32 concurrently blocks HCV and HIV-1 infections via a similar mechanism of action  Academic Article
• The role of tripartite motif family members in mediating susceptibility to HIV-1 infection  Academic Article
• The therapeutic application of CRISPR/Cas9 technologies for HIV  Academic Article
• Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding  Academic Article
• Trans-complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity  Academic Article
• Transcription factor GATA-1 potently represses the expression of the HIV-1 coreceptor CCR5 in human T cells and dendritic cells  Academic Article
• Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers  Academic Article
• Transforming growth-factor-beta and noncytopathic mechanisms of immunodeficiency in human-immunodeficiency-virus infection  Academic Article
• Transforming growth-factor-beta and suppression of humoral immune-responses in HIV-infection  Academic Article
• Tumor necrosis factor in the pathogenesis of infectious diseases  Academic Article
• Two mechanisms for human immunodeficiency virus type 1 inhibition by N-terminal modifications of RANTES  Academic Article
• Type I and type II interferon coordinately regulate suppressive dendritic cell fate and function during viral persistence  Academic Article
• Update on current models of HIV-related neuronal injury: platelet-activating factor, arachidonic acid and nitric oxide  Academic Article
• Using HIV Networks to Inform Real Time Prevention Interventions  Academic Article
• Using HIV sequence and epidemiologic data to assess the effect of self-referral testing for acute HIV infection on incident diagnoses in San Diego, California  Academic Article
• V1/V2 neutralizing epitope is conserved in divergent non-M groups of HIV-1  Academic Article
• VRX-496(VIRxSYS)  Academic Article
• Vaccine elicitation of high mannose-dependent neutralizing antibodies against the V3-glycan broadly neutralizing epitope in nonhuman primates  Academic Article
• Vaccine-elicited tier 2 HIV-1 neutralizing antibodies bind to quaternary epitopes involving glycan-deficient patches proximal to the CD4 binding site  Academic Article
• Variation in hiv-i r5 macrophage-tropism correlates with sensitivity to reagents that block envelope: Cd4 interactions but not with sensitivity to other entry inhibitors  Academic Article
• Viral immunology: challenges associated with the progression from bench to clinic  Academic Article
• Viral pathogenesis in hu-PBL-SCID mice  Academic Article
• Virtual screening of integrase inhibitors by large scale binding free energy calculations: the SAMPL4 challenge  Academic Article
• Virtual screening with AutoDock Vina and the common pharmacophore engine of a low diversity library of fragments and hits against the three allosteric sites of HIV integrase: participation in the SAMPL4 protein-ligand binding challenge  Academic Article
• Virus and target cell evolution in human immunodeficiency virus type 1 infection  Academic Article
• Virus entry via the alternative coreceptors CCR3 and FPRL1 differs by human immunodeficiency virus type 1 subtype  Academic Article
• Virus-induced immunosuppression - immune system-mediated destruction of virus-infected dendritic cells results in generalized immune suppression  Academic Article
• Virus-specific cd8+ cytotoxic t-lymphocyte activity associated with control of viremia in primary human-immunodeficiency-virus type-1 infection  Academic Article
• Vitamin D time profile based on the contribution of non-genetic and genetic factors in HIV-infected individuals of European ancestry  Academic Article
• Whither or wither microbicides?  Academic Article
• ZNRD1 (zinc ribbon domain-containing 1) is a host cellular factor that influences HIV-1 replication and disease progression  Academic Article
• Zinc finger protein designed to target 2-long terminal repeat junctions interferes with human immunodeficiency virus integration  Academic Article
• eCD4-Ig variants that more potently neutralize HIV-1  Academic Article
• gp41: HIV's shy protein  Academic Article